Filing Details
- Accession Number:
- 0001140361-15-019192
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-12 18:51:03
- Reporting Period:
- 2015-05-08
- Filing Date:
- 2015-05-12
- Accepted Time:
- 2015-05-12 18:51:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293818 | Opgen Inc | OPGN,OPGNW | Services-Medical Laboratories (8071) | 061614015 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1397963 | Misti Ushio | 1450 Broadway 24Th Floor New York NY 10018 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-08 | 300,833 | $6.00 | 330,716 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2015-05-08 | 610,017 | $0.00 | 940,733 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2015-05-08 | 209,020 | $0.00 | 1,149,753 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2015-05-08 | 260,043 | $0.00 | 1,409,796 | No | 4 | C | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Redeemable Convertible Preferred Stock | Disposition | 2015-05-08 | 610,017 | $0.00 | 610,017 | $0.00 |
Common Stock | 2014 Convertible Notes | Disposition | 2015-05-08 | 209,020 | $0.00 | 209,020 | $0.00 |
Common Stock | 2015 Convertible Notes | Disposition | 2015-05-08 | 260,043 | $0.00 | 260,043 | $0.00 |
Common Stock | Warrants | Acquisiton | 2015-05-08 | 300,833 | $0.00 | 300,833 | $6.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
300,833 | 2015-05-08 | 2020-05-08 | No | 4 | P | Indirect |
Footnotes
- Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
- The 2014 Convertible Notes automatically converted into shares of Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of one share of Series A Preferred Stock for every $1.00 of principal converted. Each share of Series A Preferred Stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
- The 2015 Convertible Notes converted into Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of 1.25 shares of Series A Preferred Stock for each $1.00 of principal converted. Each share of Series A Preferred stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
- The securities are directly held by Harris & Harris Group, Inc. Dr. Ushio is Chief Strategy Officer and Managing Director of Harris & Harris Group, Inc., and may be deemed to have shared voting power over the shares owned by Harris & Harris Group, Inc. Dr. Ushio disclaims beneficial ownership of all shares held by Harris & Harris Group, Inc., except to the extent of her actual pecuniary interest therein.